Preferred-Placement

Contact Info

Blog

FDA Grants Accelerated Approval for Alzheimer’s Drug

For Immediate Release: June 07, 2021 Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over […]

Self-Care for Caregivers

The physical and emotional demands of caring for a loved one with a serious illness can be exhausting and even lead to burnout. It’s important to maintain your own health and well-being so you can provide the best possible care. Here are tips for handling some of the common challenges for caregivers: Take time for […]

Mild cognitive impairment (MCI)

Mild cognitive impairment (MCI) Overview Mild cognitive impairment (MCI) is the stage between the expected cognitive decline of normal aging and the more serious decline of dementia. It’s characterized by problems with memory, language, thinking or judgment. If you have mild cognitive impairment, you may be aware that your memory or mental function has “slipped.” […]

X